Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000723693 | SCV000112547 | uncertain significance | not provided | 2016-07-11 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000723693 | SCV000520494 | likely benign | not provided | 2018-05-02 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001081480 | SCV000560836 | benign | Duchenne muscular dystrophy | 2024-01-27 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000080645 | SCV001365653 | benign | not specified | 2019-04-17 | criteria provided, single submitter | clinical testing | The p.Ile1727Ile variant in DMD is classified as benign because it has been identified in 0.05% (14/27930) of Latino chromosomes and 20 hemizygotes by gnomAD (http://gnomad.broadinstitute.org). In addition, it does not alter an amino acid residue, it is not located within the splice consensus sequence, and splice prediction algorithms do not predict a newly created splice site. ACMG/AMP Criteria applied: BA1, BP4, BP7. |
Genome- |
RCV001081480 | SCV001716338 | benign | Duchenne muscular dystrophy | 2021-05-18 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002336233 | SCV002643724 | benign | Cardiovascular phenotype | 2018-10-03 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000723693 | SCV004700439 | likely benign | not provided | 2024-01-01 | criteria provided, single submitter | clinical testing | DMD: BP4, BP7, BS2 |
Natera, |
RCV001831856 | SCV002093530 | likely benign | Becker muscular dystrophy; Duchenne muscular dystrophy; Cardiomyopathy; Dystrophin deficiency | 2018-04-10 | no assertion criteria provided | clinical testing |